Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17450185 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Safety and Efficacy Trial for Alpha-Beta Depleted T-Cell Infusions Post Haplo Transplant
Conditions: Hematologic Neoplasms;   Graft-Versus-Host Disease
Intervention: Device: Alpha-beta depleted T-cell infusion after post-transplant cyclophosphamide.

Indicates status has not been verified in more than two years